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Abstract
 .The NarK pump current I of single HEK293 cells either untransfected endogenous I or transfected with the a1p p
 .subunit of the rat NarK pump exogenous I was investigated in Na-containing solution by means of whole-cell recordingp
y4 y4  .at 308C. The endogenous I was irreversibly blocked by 10 M ouabain or 2P10 M dihydro-ouabain DHO . Its densityp
amounted to 0.33 pA pFy1 at 0 mV and 5.4 mM K . It was half maximally activated at 1.5 mM K and increased linearlyo o
 .with depolarization over the entire voltage range studied y80 to q60 mV . In contrast, HEK293 cells stably transfected
with cDNA for the cardiac glycoside-resistant a1 subunit of the rat NarK pump showed an I in the presence of 10y4 Mp
ouabain and 2P10y4 M DHO, respectively. This exogenous I was reversibly blocked by 10y2 M ouabain. Half maximalp
activation of the exogenous I occurred at 1.7 mM K . Its amplitude increased linearly with depolarization at negativep o
voltages but remained almost constant at positive membrane potentials. Comparison with the I of isolated rat cardiacp
ventricular myocytes strongly suggests that the exogenous I in HEK293 cells is generated by the a1 subunit of the ratp
NarK pump since it displays identical properties. Therefore, HEK293 cells represent an expression system well suited for
the electrophysiological analysis of recombinant, cardiac glycoside-resistant NarK pumps by means of whole-cell
recording.
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1. Introduction
In recent years HEK293 cells human embryonic
.kidney cells , a mammalian cell line, have been used
as a system for the heterologous expression of trans-
w xporters and ion channels 1,2 . Due to their small
volume, the cells are well suited for studies on en-
dogenous and exogenous ion channels and trans-
porters by means of whole-cell recording. In contrast
to conventional voltage-clamping on larger cells e.g.,
) Corresponding author: Fax: q49 234 7094129.
. w xXenopus oocytes the patch-clamp technique 3 al-
lows a good control of the composition of the cell
interior and renders possible a change of the intra-
w xcellular solution during the experiment 4 . Apart
 w x.from some fundamental data e.g. Ref. 1 , informa-
tion about the electrophysiological characteristics of
HEK293 cells is scanty. It is, however, clear that
endogenous, voltage-activated Ca or Na channels are
w xabsent in these cells 2 . The aim of the experiments
described below was two-fold. First, we studied the
current produced by the endogenous NarK pump
molecules in order to contribute to the electrophysio-
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logical characterization of the cells. Second, we tested
whether HEK293 cells could express exogenous
NarK pumps and thus could provide a system for the
analysis of the NarK pump current generated by
exogenous pump molecules by means of whole-cell
recording. Such a system would markedly facilitate
the electrophysiological analysis of the NarK pump
structure-function relationship. Most recently, Ya-
w xmamoto and co-workers 5 reported on a successful
electrophysiological analysis of recombinant, mutated
NarK pumps expressed in HeLa cells. Their study
concentrated on the kinetics of K y and cardiaco
glycoside-binding to wild-type and mutated pump
molecules. The experiments described below, how-
ever, characterize different aspects of endogenous
and recombinant NarK pumps in HEK293 cells. In
addition the properties of the rat a1 subunit in
recombinant and wild-type pumps are compared.
Some of the results have been published in abstract
w xform 6 .
2. Materials and methods
2.1. Cell culture
HEK293 cells were maintained in culture flasks
 2. 25 cm with Minimal Essential Medium MEM;
.Life Technologies GmbH, Eggenstein, Germany
 .supplemented with 10% vrv fetal bovine serum
 .Bio Whittaker, Verviers, Belgium , 20 mM L-
 .glutamine, 1% vrv MEM non-essential amino acids,
100 000 I.U.rl penicillin, and 100 mgrl streptomycin
 .all from Life Technologies, Eggenstein, Germany at
378C and 5% CO . The culture medium was replaced2
every 2–3 days. When the cells were grown to near
confluency, they were trypsinized and seeded at a
density of 4000 cmy2 in a new culture flask.
2.2. Transfection and selection of stably transfected
cells
The eucaryotic expression plasmid pR a1 was used
w xfor the transfection of the HEK293 cells 7 . It is
derived from the plasmid pRcrCMV Invitrogen
.Corporation, San Diego, USA and contains the
cDNA of the a1 subunit of the rat NarK pump
under the control of the enhancer-promotor regions of
the immediate early gene from the human cy-
tomegalovirus. HEK293 cells were transfected with
pR a1 by means of the Ca phosphate coprecipitation
w xmethod 8 . Shortly, two days before transfection
f1P105 HEK293 cells were seeded in a culture
flask. On the day of transfection, 250 ml 2=Hepes-
buffered saline in mM: 280 NaCl, 2.8 Na HPO , 502 4
N-2-hydroxyethylpiperazine-N X-2-ethane-sulfonic
 .  ..acid Hepes , pH 7.2 NaOH were gently mixed
with 250 ml of a 250 mM CaCl solution containing2
14 mg pR a1. Five min later, 240 ml of the resulting
solution were added dropwise to the cells in the
 .culture flask 2.5 ml culture medium . The cells were
 .kept in the incubator 378C, 5% CO for 3 h.2
Afterwards they were washed twice with phosphate-
buffered saline in mM: 0.9 CaCl P2 H O, 2.7 KCl,2 2
1.5 KH PO , 0.5 MgCl P6 H O, 106 NaCl, 6.52 4 2 2
 ..Na HPO , pH 7.2 NaOH and kept in culture2 4
medium for two days. To obtain stably transfected
y4  .cells, 10 M dihydro-ouabain DHO was then per-
manently added to the medium.
 .Mock transfection plasmid pRcrCMV only re-
vealed that all cells died within two days in the
DHO-containing culture medium. This observation
excludes the possibility that HEK293 cells became
ouabain-resistant by mutations of their endogenous
a1 subunit.
2.3. Preparation of single rat ˝entricular myocytes
Isolation of single myocytes was carried out ac-
w xcording to Bechem and co-workers 9 . Briefly, adult
female Wistar rats were anaesthesized with dieth-
ylether and killed by decapitation. The aorta was
cannulated before the heart was excised, mounted on
a Langendorff apparatus, and perfused at 378C for
 .several minutes with the following solutions in mM :
 .1 Ca-free solution: 204 sucrose, 35 NaCl, 5.4 KCl,
1.0 MgCl , 2.0 ethylene glycol-bis b-aminoethyl2
. X X  .ether -N,N,N ,N -tetraacetic acid EGTA , 10 Hepes;
 .2 enzyme solution: 204 sucrose, 35 NaCl, 5.4 KCl,
1.0 MgCl , 0.1 EGTA, 10 Hepes; 0.5 mgrml bovine2
 .serum albumine BSA; Sigma, Germany , 0.4 mgrml
 .collagenase B Boehringer Mannheim, Germany , 10
 .mlrml elastase Serva, Heidelberg, Germany , 0.3
 .mgrml protease Sigma, Germany , 0.15 mgrml
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 .DNase Sigma, Germany . The pH of the oxygenated
solutions was 7.4. The digested ventricles were cut
into pieces and gently stirred at 20–228C in tissue
wells containing a nominally Ca-free solution with
 .the following composition in mM : 204 sucrose, 35
NaCl, 5.4 KCl, 1.0 MgCl , 10 Hepes; 1.0 mgrml2
w xBSA, 0.3 mgrml DNase, pH 7.4. Ca was increased
to 1.3 mM by stepwise replacement with Hanks’
 .medium 199 PAA, Linz, Austria supplemented with
100.000 I.U.rl penicillin, 100 mgrl streptomycin,
and 250 mgrl amphotericin B all from Sigma, Ger-
.many . Isolated myocytes were transferred to culture
 .dishes B 35 mm and used for the electrophysiologi-
cal experiments either immediately after isolation or
 .after one day in culture 378C, 3% CO .2
2.4. Whole-cell recording
 .A culture dish B 35 mm with either HEK293
cells or rat ventricular myocytes was fixed to the
stage of an inverted microscope Diaphot TMD,
.Nikon, Tokyo, Japan . The dish was perfused with
extracellular solution from a reservoir connected to
the dish by plastic tubes. It was placed about 100 cm
above the stage. Solution flow, driven by gravity,
was 1 mlrmin. The solution level in the dish was
held constant by means of an outlet opposite to the
inlet from the reservoir. A multibarreled pipette in-
.ner diameter: 500 mm was placed 100–200 mm
from the cell under investigation. The cell was con-
tinuously superfused at a rate of 0.4 mlrmin with
one of the solutions from reservoirs connected with
the pipette via plastic tubes. The reservoirs were
about 30 cm above the stage. Solution changes, con-
trolled by electromagnetic valves The Lee Company,
.Westbrook, USA , had a time constant of 200–600
w xms 10 . The temperature in the vicinity of the cell
was 308C when superfused with one of the test
solutions. Patch pipettes were made from borosilicate
glass capillaries GC150TF-10, Clark Electromedical
.Instruments, Reading, UK and back-filled with the
pipette solution. They had an initial resistance be-
tween 2.5 and 7 MV for experiments with HEK293
cells and between 1 and 2.5 MV for experiments
with rat ventricular myocytes. The tip potential be-
tween the patch pipette and the extracellular solution
was compensated before establishing a GV seal G
.10 GV . Gentle suction was applied to a patch
pipette positioned at the cell membrane to obtain the
whole-cell configuration of the patch-clamp tech-
w xnique 3 . The cells were voltage-clamped by means
of an EPC-7 patch clamp amplifier List Medical,
.Darmstadt, Germany . The amplifier was connected
to a personal computer via 12 bit AD- and DA-con-
verters, respectively. Currents were low-pass filtered
at 200 Hz and digitized with 1 kHz 200 Hz in early
. experiments . The programme ISO2 MFK, Niedern-
.hausen, Germany was used to generate the voltage
protocols and to record the resulting currents. The
cell capacitance was determined by a programme
routine that applied depolarizing and hyperpolarizing
voltage ramps 10 mV in amplitude starting from a
holding potential of 0 mV. HEK293 cells displayed
membrane capacitances between 20 and 85 pF,
whereas rat ventricular myocytes showed values be-
tween 60 and 160 pF.
2.5. Solutions for whole-cell recording
The extracellular solution for whole-cell recording
 .contained in mM : 144 NaCl, 0–10.8 KCl, 5 NiCl ,2
2 BaCl , 1.8 CaCl , 0.5 MgCl , 10 Hepes, pH 7.42 2 2
 .NaOH . Barium and nickel served to suppress potas-
sium and calcium conductances, respectively, as well
as the sarcolemmal NarCa exchanger. DHO Roth,
. Karlsruhe, Germany and ouabain Fluka Chemie
. y2AG, Buchs, Switzerland were added from 10 M
stock solutions. The DHO stock solution was aque-
ous, whereas the ouabain stock solution contained
 .10% vrv ethanol. In experiments, in which
w x y2ouabain was 10 M, the drug was solved directly
in the extracellular solution. In this case, the super-
 .fusate contained 2% vrv ethanol. Control experi-
w xments revealed that this ethanol had no influence on
the membrane current under the present experimental
conditions.
 .The pipette solution was composed of in mM :
110 CsCl, 40 NaCl, 10 NaOH, 3 MgCl , 6 EGTA, 162
 .Hepes, 10 MgATP, pH 7.4 CsOH . Assuming a
y6 w xcontamination of f1P10 M Ca, free Ca and
w x y11Mg were calculated to be 1.3P10 M and 2.4P
y3 w x10 M, respectively 11 . The solution contained
cesium to block potassium conductances and a high
w xNa to strongly activate the NarK pump at internal
sites.
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2.6. Statistics
Whenever possible data are presented as mean"
S.E.M. The S.E.M. is only shown in the figures when
it exceeds the size of the symbol. n indicates the
number of cells studied. Differences between data
points were checked by Student’s two-tailed, un-
paired t-test and considered significant if P-0.05.
3. Results
3.1. The endogenous Ip
The NarK pump is an ATP-consuming enzyme,
that transports 3 Na ions out of and 2 K ions into the
cell per each ATP molecule split. The net movement
of one positive charge out of the cell during each
NarK pump cycle thus produces an outward current.
w xThe NarK pump current I depends on K and canp o
be blocked by cardiac glycosides, specific inhibitors
of the NarK pump. Fig. 1 shows the identification of
the NarK pump current of HEK293 cells endoge-
.nous I . The holding potential V is 0 mV. Horizon-p C
tal lines above the current trace indicate changes of
the superfusion solution. In Fig. 1A, a HEK293 cell
is initially superfused with extracellular solution, that
contains 144 mM Na and 5.4 mM K. Switching to
 .K-free solution 0 K immediately shifts the holding
current by about 20 pA in the inward direction. The
following application of 10y4 M ouabain results in
an inward current shift of the same amplitude but
with a slower time course. Fig. 1B displays a similar
experiment with another HEK293 cell. At the begin-
ning the cell is superfused with a solution containing
5.4 mM K. K-free medium instantaneously blocks an
outward current of 10 pA. 2P10y4 M DHO more
slowly blocks an outward current component of the
same amplitude. As can be seen in Fig. 1A,B, under
the chosen experimental conditions the cardiac glyco-
side-sensitive outward current is virtually identical to
the current activated by K . This outward current iso
the current generated by the NarK pump. However,
in contrast to K-free medium the block of I byp
cardiac glycosides was nearly irreversible. Even after
5–10 min in cardiac glycoside free solution, there
was no recovery of I . The I density at 5.4 mM Kp p o
y1 and 0 mV amounted to 0.33"0.02 pAPpF ns
.28 .
Fig. 1. Identification of the endogenous I in HEK293 cells. I isp p
identified as current inhibited by cardiac glycosides or K-free
solution. In this and the following figures solution changes are
indicated by horizontal lines above the current traces and the
horizontal calibration mark denotes zero current level. The hold-
 .ing potential V is 0 mV. A Initially, the superfusate containsC
5.4 mM K . Application of K-free solution or of a mediumo
y4  .containing 10 M ouabain 5.4 mM K results in an identicalo
inward shift of the membrane current. Thus, the amplitudes of Ip
 .estimated by either procedure are identical. B Different cell.
The I amplitudes estimated by application of a K-free mediump
y4 or a solution containing 2P10 M dihydro-ouabain DHO; 5.4
.mM K are almost the same.o
The following experiments were all performed at a
holding potential of 0 mV, except for the measure-
 .ments of the NarK pump current-voltage I -Vp
relationships.
The concentration-dependent inhibition of the en-
dogenous I by DHO is illustrated in Fig. 2. Fig. 2Ap
shows the effect of 5P10y6 M DHO on the endoge-
nous I of a HEK293 cell. At the beginning of thep
record the cell is superfused with a solution contain-
ing 5.4 mM K. Solution changes are indicated by the
bars above the current trace. Switching to K-free
w xsolution reveals an I amplitude of 12 pA. A DHOp
of 5P10y6 M slowly shifts the holding current by 2.5
pA in the inward direction, i.e., it inhibits 21% of the
initial I . Changing the superfusate to K-free solutionp
during the steady-state inhibition by DHO causes a
further inward shift of the current by 9.5 pA, corre-
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 .Fig. 2. Inhibition of I by DHO in native HEK293 cells. Ap
Original record. At the beginning the cell is superfused with a
solution containing 5.4 mM K . I amplitudes are estimated byo p
short pulses of K-free solution. Application of 5P10y6 M DHO
 .  .with 5.4 mM K reduces the initial I amplitude 12 pA by 2.5o p
 .pA or 21%. B Concentration–response curve of steady-state Ip
 .inhibition by DHO with 5.4 mM K . Complete inhibition of Io p
in a K-free medium is arbitrarily set to 1. Data are shown as
 .means"S.E.M. nG3 . Error bars are given only if they exceed
the size of the symbols. The sigmoid curve fitted to the data
represents a logarithmic version of the Hill equation. Half maxi-
 . y5mal inhibition of I EC occurs at 1.1P10 M DHO with ap 50
Hill coefficient n of 1.2.H
sponding to 79% of the initial I amplitude. Thep
w xapplication of various DHO on 21 HEK293 cells
resulted in the concentration–response curve pre-
sented in Fig. 2B. The relative steady-state inhibition
of I by DHO is plotted versus the logarithm of thep
w xDHO . Each data point represents the mean of at
least three measurements. The sigmoid curve fitted to
the data obeys a logarithmic version of the Hill
equation. According to this fit half maximal I inhibi-p
 . y5tion EC occurs at 1.1P10 M DHO with a Hill50
coefficient n of 1.2, in line with the notion that oneH
DHO molecule binds to one NarK pump molecule.
We next studied the dependence of the endogenous
w xI on K . For this purpose solutions containingp o
w xvarious K were applied to the cells. An original
record of such an experiment is shown in Fig. 3A. A
HEK293 cell is superfused with solutions containing
0, 1.35, 2.7, or 5.4 mM K, as indicated by the lines
above the current trace. The membrane current is
shifted in the outward direction with increasingly
w xhigher K . The difference in holding current be-o
tween K-containing and K-free solution represents
w xthe I amplitude at the respective K . I amplitudesp o p
were normalized to the amplitude at 5.4 mM K ando
w xplotted versus K . The result is shown in Fig. 3B.o
Each data point is the mean of 2–12 measurements.
The curve fitted to the data points represents the Hill
equation:
n nH HnHI s I P K r K q K . 1 . .p pmax . 0.5o o
 .The maximal NarK pump current I is 1.21,pmax.
half-maximal activation of I occurs at 1.5 mM Kp o
 .K , and the Hill coefficient n amounts to 1.2.0.5 H
 .Fig. 3. Activation of the endogenous I by K . A Originalp o
 .record. Increasing external K concentrations horizontal bars
evoke an increasing outward component of membrane current
 .bottom trace . Note that the K -activated outward current tendso
w x  .to saturate at high K . B Normalized concentration-responseo
curve of I activation by K . I amplitudes were normalized top o p
the amplitude at 5.4 mM K , which was arbitrarily set to 1.o
Numbers in parentheses indicate the number of cells studied. The
  ..curve fitted to the data obeys the Hill equation Eq. 1 : Ipmax.
s1.21; K s1.5 mM K ; n s1.2.0.5 o H
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It is well known that I is voltage-dependent re-p
w x.view: Ref. 12 . Fig. 4 illustrates the voltage-depen-
dence of the endogenous I , which was determinedp
by means of the protocol depicted in Fig. 4A. The
upper trace in Fig. 4A represents the voltage proto-
 .Fig. 4. I -V curve of native HEK293 cells. A Estimation of Ip p
 .at various membrane potentials top line . The superfusate con-
tains 5.4 mM K . I is measured as current reactivated by Ko p o
after a short pulse of a K-free medium, indicated by the short
 .lines above the current trace bottom . During the application of
K-free solution the membrane current is shifted in the inward
 .direction at each potential tested. B Enlarged current traces
 .from A , ordered by membrane potential. Bars indicating changes
to K-free medium are left. I is estimated as current reactivatedp
by 5.4 mM K after superfusion with K-free medium. I in-o p
 .creases with depolarization. C Normalized mean I -V relation-p
ship of native HEK293 cells. I amplitudes are normalized to thep
corresponding amplitude at zero potential. Data represent means
 ."S.E.M. ns4–15 . The inset shows the normalized I -V curvep
 .  .obtained in the experiment illustrated in A and B .
col, whereas the lower trace shows the resulting
membrane current of a HEK293 cell. The cell was
clamped to voltages between y80 and q60 mV in
20 mV steps. Changes in the membrane potential
result in capacitative artifacts visible as rapid upward
and downward deflections in the current trace, re-
spectively. The cell is continuously superfused with a
solution containing 5.4 mM K. During each clamp
potential the superfusate is temporarily changed to
K-free solution, as marked by the horizontal bars
above the current trace. K-free solution shifts the
membrane current in the inward direction at each
potential tested. This is shown in further detail in Fig.
4B. Magnified current traces from Fig. 4A are pre-
sented. They were obtained during superfusion with
K-free solution. For clarity bars indicating changes to
K-free solution are left. Two traces at zero potential
are shown, the first from the beginning and the
second from the end of the record in Fig. 4A. Since
the difference current at this potential remains con-
stant, changes of the seal resistance during the record
can be excluded. It is clear from Fig. 4B that the
difference in membrane current between K-contain-
ing and K-free solution increases with increasing
membrane potential. This difference current repre-
sents I because K-activated and cardiac glycoside-p
sensitive current are identical under the present ex-
 .perimental conditions cf. Fig. 1 . Control experi-
 .ments not shown confirmed that this is not only true
for 0 mV but for all potentials in the voltage range
studied. I amplitudes were normalized to the ampli-p
tude at 0 mV and plotted versus membrane potential
to yield the I -V relationship shown in the inset inp
Fig. 4C. Normalized I amplitudes range from 0.41p
at y80 mV to 1.32 at q60 mV. The I -V curve isp
nearly linear over this voltage range. The main Fig.
4C illustrates the mean I -V relationship for thep
endogenous I . Mean values of 4–15 measurementsp
for each potential are presented. Normalized I am-p
 .plitudes are 0.55"0.03 ns10 at y80 mV and
 .1.38"0.05 ns4 at q60 mV. This mean I -Vp
curve is almost linear over the entire voltage range
studied.
3.2. The exogenous Ip
After the characterization of the cardiac
glycoside-sensitive endogenous I , we investigatedp
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whether a cardiac glycoside-resistant I could bep
detected in HEK293 cells transfected with the a1
subunit of the rat NarK pump. Fig. 5 displays the
membrane current of a HEK293 cell transfected with
the a1 subunit of the rat NarK pump and cultured
for 44 days in a medium containing 10y4 M DHO.
w x  .This DHO blocks the endogenous I cf. Fig. 2B .p
The horizontal lines above the current trace indicate
changes of the superfusate. At the beginning of the
record the cell is superfused with a solution contain-
ing 5.4 mM K plus 2P10y4 M DHO. As can beo
seen from Fig. 5 a K-free solution or a solution
containing 5.4 mM K plus 10y2 M ouabain block an
almost identical outward component of the membrane
current. Thus, a NarK pump current is present under
conditions which completely block the endogenous
I . The density of this NarK pump current amountedp
y1  .to 0.16"0.02 pAPpF ns11 . In contrast to the
irreversible blockade of the endogenous I by ouabainp
or DHO the I inhibition by ouabain in transfectedp
cells is reversible. I recovers in the presence of ap
solution containing 2P10y4 M DHO. Obviously, the
transfected cells expressed NarK pumps exhibiting a
much lower ouabain sensitivity than the endogenous
NarK pumps. Assuming one-to-one binding of
Fig. 5. Blockade of the exogenous I by 10y2 M ouabain isp
 .  .partially reversible. Original current record bottom from a
HEK293 cell stably transfected with the rat a1 subunit. The cell
is continuously superfused with a medium containing 5.4 mM K o
plus 2P10y4 M DHO except for short periods of K-free or
 y2 .ouabain-containing 10 M solution, as marked by the bars
above the current trace. I is estimated either as current blockedp
by K-free solution or as current inhibited by 10y2 M ouabain
 .5.4 mM K . Both estimates are nearly identical. At the end ofo
the record I amounts to f75% of the initial amplitude. Thep
apparent increase and decrease, respectively, of the current noise
 .in passing zero current level dashed line is an artifact due to the
data acquisition programme.
ouabain to the NarK pump an estimation of the
 X .apparent K value K for I inhibition by ouabaind d p
can be derived from the kinetics of ouabain-binding
and -unbinding for a detailed description of this
w x.procedure see Ref. 13 . Consequently, I inhibitionp
and recovery were presumed to proceed monoexpo-
 .nentially. The time constant of I inhibition tp
 .amounted to 1.3 s, whereas that for I recovery tp off
was 64.9 s. Hence, the K X value was calculated to bed
2.0P10y4 M. Similar results were obtained on two
 X y4other cells K values: 2.5 and 2.7P10 M, respec-d
. Xtively . The mean K for the inhibition of the exoge-d
 . y4  .nous I by ouabain was 2.4"0.2 P10 M ns3 .p
Since rat NarK pumps are known to be ouabain-in-
sensitive, these results strongly suggest that the trans-
fected cells expressed a functional NarK pump which
contained the rat a1 subunit and displayed, therefore,
the characteristic ouabain-resistance.
The K -dependence of the exogenous I was deter-o p
w xmined in media containing different K plus eithero
10y4 M ouabain or 2P10y4 M DHO to block the
w xendogenous I . Raising K resulted in an outwardp o
 .shift of the holding current not shown . I wasp
estimated as the difference in the holding current
measured during application of a K-free solution. I p
amplitudes were normalized to the I amplitude atp
w x5.4 mM K and plotted versus K . Fitting with theo o
  ..Hill equation Eq. 1 yielded a maximal I of 1.33,p
a K of 1.7 mM K , and a Hill coefficient of 1.0.5 o
These values hardly differ from those obtained for
 .the endogenous I cf. Fig. 3B .p
The voltage dependence of the exogenous I inp
transfected HEK293 cells was studied as shown in
Fig. 4 for the endogenous I . The cells were continu-p
ously superfused with solutions containing 5.4 mM
K plus 2P10y4 M DHO or 10y4 M ouabain,o
respectively. I was estimated as K -activated currentp o
at membrane potentials between y80 and q60 mV
in 20 mV steps. For this purpose a K-free solution
was applied to the cell under study for a few seconds
at each membrane potential. Measurements on 6 cells
 .summarized in Fig. 7, open circles revealed that I p
increased with depolarization at negative voltages.
However, it remained essentially constant at positive
potentials in contrast to the endogenous I of untrans-p
fected cells which increased linearly over the entire
 .range of membrane potentials Fig. 4C . Normalized
mean amplitudes of the exogenous I varied betweenp
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 .0.42"0.04 at y80 mV ns2 only and 1.09"0.03
 .at q60 mV ns4 only .
3.3. The contribution of the endogenous and exoge-
nous I to the total I of transfected HEK293 cellsp p
The contribution of endogenous and exogenous
NarK pumps to the total I of transfected HEK293p
cells was estimated in the following way. First, the
transfected cells were cultured for 2–3 days in a
DHO-free medium in order to abolish the inhibition
of the endogenous NarK pumps which was induced
by the DHO-containing culture medium. Afterwards
the total I of the cells was estimated as K -activatedp o
current. The total I density amounted to 0.20"0.03p
y1  .pAPpF ns7 . The total I was then inhibited inp
two steps. Application of a superfusate containing 5.4
mM K plus 10y4 M ouabain completely blocked the
endogenous I of the HEK293 cells. Subsequentp
superfusion with a solution containing 5.4 mM K
plus 10y2 M ouabain blocked the residual I whichp
was most probably generated by pump molecules
containing the exogenous a1 subunit of the rat NarK
pump. Fig. 6 illustrates this procedure. Fig. 6A dis-
plays an original record from a HEK293 cell. Changes
of the superfusate are indicated by the horizontal
lines above the current trace. At the beginning of the
experiment the total I is estimated as the currentp
inhibited by K-free solution. It amounts to 15 pA.
The application of 10y4 M ouabain shifts the mem-
brane current in the inward direction by 5.2 pA or
 .35% of the total I . The residual 65% 9.8 pA of thep
total I are then blocked by 10y2 M ouabain. As ap
mean from 7 cells 37"3% of the total I werep
inhibited by 10y4 M ouabain. Therefore, at least
f63% of the total pump current were generated by
NarK pumps containing the exogenous, ouabain-re-
sistant rat a1 subunit. If 10y4 M ouabain blocked
some of these pump molecules, the contribution of
the exogenous pumps to the total I would be evenp
larger. For comparison, similar measurements were
carried out on rat ventricular myocytes. It is known
from electrophysiological and biochemical studies
w x14,15 that about 70–80% of the NarK pumps in
these cells contain the ouabain-resistant a1 subunit.
Fig. 6B shows the membrane current of a rat ventric-
ular cell. Initially, the total I is estimated as currentp
inhibited by K-free solution. I amounts to 60 pA.p
Fig. 6. Contribution of ouabain-insensitive I to the total I ofp p
transfected HEK293 cells and native rat ventricular myocytes.
 .A Contribution of the exogenous, ouabain-resistant I to thep
total I in a stably transfected HEK293 cell. The cell wasp
cultured for two days in DHO-free medium in order to abolish
inhibition of the endogenous NarK pumps. Original record of
 .membrane current bottom trace . Solution changes are indicated
by the horizontal lines above the current trace. At the beginning
of the record the cell is superfused with a medium containing 5.4
mM K . Total I is estimated twice as current blocked by K-freeo p
y4  .solution. Application of 10 M ouabain with 5.4 mM K o
diminishes the total I by 35%. The residual I is blocked byp p
y2  .10 M ouabain with 5.4 mM K . Thus, the exogenous,o
ouabain-resistant I contributes at least 65% to the total I of thep p
 .cell. B Contribution of ouabain-insensitive NarK pump
molecules to the total I of a rat ventricular myocyte. Applicationp
of different media is visualized by the bars above the current
trace. Initially, the superfusate contains 5.4 mM K . Total I iso p
measured as current blocked by K-free solution. A medium
y4  .containing 10 M ouabain with 5.4 mM K inhibits 17% ofo
the total I . Complete block of I occurs following application ofp p
y2  .10 M ouabain with 5.4 mM K . The ouabain-insensitiveo
NarK pumps contribute at least 83% to the total I of thep
 .  .myocyte. Dashed lines in A and B are drawn to facilitate the
identification of the I components.p
10y4 M ouabain inhibits 10 pA or 17% of the total
I . The remaining pump current is completely blockedp
by 10y2 M ouabain. This component is most proba-
bly due to the ouabain-resistant pump molecules con-
taining the a1 subunit. Corresponding experiments
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on 5 myocytes revealed that 23"4% of the total I p
y4 were blocked by 10 M ouabain. Thus, 77% at
.least of the total I were generated by pumpp
molecules containing the ouabain-resistant a1 sub-
unit. These results are in quantitative agreement with
the reports mentioned above. It is, however, difficult
to exclude that a small portion of the pumps contain-
ing the a1 subunit were already blocked by 10y4 M
ouabain.
3.4. I -V relationships of transfected and not-trans-p
fected HEK293 cells and of rat ˝entricular myocytes
Fig. 7 displays mean I -V relationships of normalp
 . v; ns4–15 and transfected ‘; ns4–6, ns2
.only at y80 mV HEK293 cells. For comparison the
I -V curve of rat ventricular myocytes is also pre-p
 .sented I; ns4–10 . For each series of experi-
ments the I amplitudes measured at the variousp
potentials were normalized to the respective ampli-
 .tude at 0 mV cf. Fig. 4 . The pump current of the
 .native untransfected HEK293 cells, i.e., the endoge-
nous I , increases almost linearly with depolarizationp
Fig. 7. Normalized mean I -V relationships of HEK293 cells andp
rat ventricular myocytes. In each series of experiments the Ip
amplitudes measured at the various membrane potentials are
normalized to the corresponding amplitude at zero potential,
 .arbitrarily set to 1. The endogenous I v of native HEK293p
 .cells ns4–15 exhibits a linear voltage dependence over the
entire range of membrane potentials studied. In contrast, the I -Vp
curves of transfected HEK293 cells exogenous I : ‘; ns4–6;p
. ns2 only at y80 mV and of rat ventricular myocytes I;
.ns4–10 show nearly constant I amplitudes at positive volt-p
ages. Both curves are almost identical. Asterisks mark signifi-
 .cantly different I amplitudes P -0.05 .p
over the entire voltage range studied. This is in
contrast to the I -V relationship of the transfectedp
HEK293 cells and to the I -V curve of the ventricularp
myocytes. Both curves are nearly identical. They
show a positive slope at negative membrane poten-
tials but little variation at positive voltages. The
similarity between both I -V curves suggests oncep
more that the transfected HEK293 cells express NarK
pumps which contain the rat a1 subunit like the
majority of the rat cardiac NarK pump molecules
w x16 .
4. Discussion
In recent years, molecular biological approaches
enabled physiologists to examine structure-function
relationships of the NarK pump. Most studies, how-
ever, used biochemical or conventional voltage clamp
methods to characterize recombinant NarK pumps.
A cell system suitable for the investigation of recom-
binant pump molecules by means of the patch clamp
technique would be a powerful tool for the electro-
physiological analysis of structure-function relation-
ships of the NarK pump. Therefore, the aim of the
present study was to establish such a system. We
chose HEK293 cells, a human cell line widely used
for the expression of recombinant proteins. These
cells are well suited for whole-cell recording, because
of high seal resistances of up to 60 GV and because
of their relatively small size. Membrane capacitance
ranged between 20 and 85 pF, in good agreement
w xwith an earlier report 1 . Little is known about the
NarK pump of these cells, so we first characterized
the NarK pump current of HEK293 cells endoge-
.nous I .p
4.1. Characteristics of the endogenous Ip
The endogenous I was determined as currentp
blocked by the cardiac glycosides ouabain or DHO.
I density at 0 mV amounted to 0.33 pAPpFy1 in ap
solution containing 5.4 mM K . This value is rathero
small compared to excitable cells like ventricular
myocytes, where the I density is around 1 pAPpFy1p
w xor beyond 17 . Half maximal steady-state I inhibi-p
y5  .tion occurred at 1.1P10 M DHO 5.4 mM K o
with a Hill coefficient of 1.2, suggesting one-to-one
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binding to the NarK pump as previously demon-
w xstrated by Hermans and co-workers 17 . Similar
values were obtained in guinea pig ventricular my-
 y5  . w x.ocytes 1.4P10 M DHO 5.4 mM K ; 17 or ino
 y5 cardiac Purkinje cells canine: 0.4P10 M DHO 8
. w x y5 mM K 18 ; rabbit: 3.5P10 M DHO 10.8 mMo
. w x.K 13 . In human endothelial cells half maximalo
steady-state inhibition of I occurred at 2.1P10y5 Mp
 . w xDHO 11 mM K 19 . In the same study, a nearlyo
irreversible I inhibition by DHO was observed. Thisp
was also the case for the endogenous I of thep
HEK293 cells. Similarly, the endogenous I of HeLap
cells, a human cell line, was blocked nearly irre-
w xversibly by ouabain, digitoxin, and digoxin 5 . The
reason for this nearly irreversible I blockade is notp
known. To our knowledge such an irreversible Ip
inhibition has only been observed in the human cell
types mentioned above raising the possibility that this
is a property of human NarK pumps.
Under our experimental conditions I i.e., thep
.outward current blocked by cardiac glycosides was
identical to the current activated by K . Half maxi-o
mal activation of I occurred at 1.5 mM K with ap o
Hill coefficient of 1.2. Comparable results were ob-
tained for rat and guinea-pig ventricular myocytes
w x w x17,20,21 , for rabbit sino-atrial node cells 22 , for
w xcardiac Purkinje cells 18 , for human endothelial
w x cells 19 , and for various other cell types cf. Ref.
w x.23 . Obviously, K -activation of I does not differo p
substantially between different cell types and species.
The endogenous I was voltage dependent. I in-p p
creased linearly over the whole voltage range studied,
i.e., between y80 and q60 mV. This monotonic
increase argues for only one voltage-dependent par-
tial reaction in the pump cycle under the present
 w x.experimental conditions cf. Ref. 12 . The main
voltage-dependent step is most probably located in
w xthe Na-translocating branch of the pump cycle 24,25
and is favoured by more positive membrane poten-
tials. An I -V relationship similar to that in HEK293p
w xcells was found in human endothelial cells 19 . I p
increased linearly between y150 and q50 mV in
these cells. Such linear I -V curves are in contrast,p
however, to those obtained in the majority of cell
types, including various cardiac cells, where I in-p
creases linearly with depolarization at negative mem-
brane potentials but shows little voltage dependence
w xat positive potentials 12,22,26–28 . The lack of volt-
age dependence at positive potentials can be ex-
plained by assuming that Na translocation is no longer
rate-determining at these voltages. For the linear I -Vp
curves of HEK293 and human endothelial cells it
means that Na translocation must be rate-determining
even at positive potentials up to q60 mV.
4.2. The heterologous expression of NarK pump
molecules in ˝arious cells
The heterologous expression of cardiac glycoside-
resistant NarK pumps in cells expressing glycoside-
sensitive endogenous pumps is an established method
for analyzing the structure–function relationship of
the NarK-ATPase. For example, HeLa cells have
been widely used for the expression of glycoside-re-
sistant, mutated a subunits of the rat or sheep NarK
pump in order to study the functional differences
between various a subunits and the significance of
distinct amino acids for cation pumping e.g., Refs.
w x.29–31 . These studies were mainly carried out by
means of biochemical methods. Similarly, Xenopus
lae˝is oocytes represent a suitable expression system
w xfor recombinant NarK pump molecules 32,33 . The
properties of the exogenous pump molecules can be
measured both by biochemical and conventional elec-
trophysiological methods. In the present study
HEK293 cells were chosen for the expression of
NarK pump molecules containing the cardiac glyco-
side-resistant rat a1 subunit of the pump.
4.3. The identification of exogenous NarK pumps in
HEK293 cells
We kept the transfected HEK293 cells for several
weeks in media containing 10y4 M DHO, which
completely blocked the endogenous glycoside-sensi-
tive NarK pumps. Under these conditions a NarK
 .pump current was identified Fig. 5 , suggesting the
functional expression of pump molecules containing
the transfected glycoside-resistant a1 subunit of the
rat NarK pump. Similar to the rat cardiac NarK-
 w x.ATPase e.g., Ref. 14 these pumps were blocked
only by the extremely high ouabain concentration of
y2  .10 M Fig. 5 . The functional expression of NarK
pumps containing the rat a1 subunit implies the
assembly of the exogenous a and the endogenous b
subunits of the molecules. Such an assembly has been
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w xreported before from Xenopus oocytes 34 , COS-1
w x w xcells 35 , and HeLa cells 30 . The assembly of the
rat a1 subunit and the endogenous b subunit in
HEK293 cells is not unexpected since human and rat
w xa subunits are nearly homologous 33 . The total I p
density of the transfected HEK293 cells amounted to
0.20 pAPpFy1 or 61% of the I density of untrans-p
w xfected cells. Similarly, Putnam and co-workers 36
reported that the total ATPase activity of HeLa cells
transfected with the rat a1 subunit was about 60% of
the controls. Since exogenous and endogenous a
subunits compete for assembly with the available
endogenous b subunits, increased I density in thep
transfected cells would be surprising. Furthermore,
the procedure of transfection per se tends to diminish
w xthe level of expressed pump molecules 35,37 . In
contrast to these findings, however, is the observation
w xof Yamamoto and co-workers 5 that the NarK
pump current densities in native and transfected HeLa
cells were almost identical. Our results illustrated in
Fig. 6A revealed that at least 63% of the total I p
density in transfected HEK293 cells are generated by
pump molecules containing the rat a1 subunit. This
is in line with the observation that 51% of the
NarK-ATPase activity of COS-1 cells transfected
with the rat a1 subunit are caused by pumps contain-
w xing the rat subunit 35 . According to Putnam and
w xco-workers 36 less than 50% of the total NarK-
ATPase activity in HeLa cells transfected with vari-
ous rat a subunits are due to molecules containing
the exogenous subunit. However, in HeLa cells trans-
fected with a mutated sheep a1 subunit up to 90% of
the total NarK-ATPase activity are produced by
w xpumps containing the sheep subunit 29 . Finally, in
HeLa cells transfected with a mutated human or
sheep a1 subunit the whole pump current is appar-
w xently generated by recombinant pump molecules 5 .
4.4. Characteristics of the exogenous Ip
In contrast to the inhibition of I by ouabain inp
native HEK293 cells the blockade of I by the car-p
diac glycoside in transfected cells was reversible.
 X .Estimation of the apparent K value K from thed d
kinetics of ouabain-binding and -unbinding yielded
2.4P10y4 M, a concentration that completely blocks
the endogenous I . Since both the time constant forp
 .solution exchange 200–600 ms as well as that for Ip
 . Xinhibition 1.1–1.4 s are similar, the calculated Kd
value has to be considered a rough estimate that tends
to overestimate the ‘correct’ K X . Despite this limita-d
tion, the value obtained by our procedure agrees
X  y4 .fairly well with the K value 3P10 M reportedd
w xby Berlin and co-workers 14 for the inhibition of Ip
by ouabain in rat ventricular myocytes under slightly
 .different conditions 15 mM Na ; 15 mM K . Bothpip o
the reversibility and the K X value of the I inhibitiond p
by ouabain clearly demonstrate the expression of
pump molecules containing the rat a1 subunit in the
transfected HEK293 cells. Similarly, the shape of the
I -V curve in transfected HEK293 cells strongly sug-p
gests the functional expression of pumps with the rat
subunit. Like the I -V relationship of rat ventricularp
myocytes, the I -V curve of transfected HEK293p
cells displays little variation of I at positive mem-p
brane potentials, whereas the I -V relationship ofp
native HEK293 cells is almost linear over the entire
 .range of potentials tested Fig. 7 . However, I acti-p
vation by K is similar in native and transfectedo
w xHEK293 cells. The K required for half maximal Io p
activation amounted to 1.5 mM in native cells and to
1.7 mM in transfected cells. Comparable values are
w xreported for rat ventricular myocytes 20 : 2.9 mM
w x .K ; 17 : 1 mM K .o o
In conclusion, the shape of the I -V relationshipp
and the effect of ouabain on I , but not the kineticsp
of I activation by K can be used to differentiatep o
between endogenous NarK pumps and exogenous
pump molecules containing the rat a1 subunit in
HEK293 cells. The different ouabain-sensitivity and
voltage dependence of the rat NarK pump as well as
the activation of the rat I by K are well conservedp o
in the recombinant NarK pumps in HEK293 cells,
demonstrating that this cell line is suited for the
expression and whole-cell patch clamp analysis of the
ouabain-resistant a1 subunit of the rat NarK pump.
Acknowledgements
We are indebted to Professor Jerry Lingrel
 .Cincinnati for a generous gift of the plasmid pR a1.
The authors would like to thank Professors Barry W.
 .  .Ache Daytona and Wolfgang Schwarz Frankfurt
for helpful comments on an earlier draft of the
manuscript.
( )J. Kockskamper et al.rBiochimica et Biophysica Acta 1325 1997 197–208¨208
References
w x1 Galli, A., DeFelice, L.J., Duke, B.-J., Moore, K.R. and
 .Blakely, R.D. 1995 J. Exp. Biol. 198, 2197–2212.
w x  .2 Perez-Garcia, M.T., Kamp, T.J. and Marban, E. 1995 J.
Gen. Physiol. 105, 289–306.
w x3 Hamill, O.P., Marty, A., Neher, E., Sakmann, B. and Sig-
 .worth, F.J. 1981 Pflugers Arch. 391, 85–100.¨
w x  .4 Soejima, M. and Noma, A. 1984 Pflugers Arch. 400,¨
424–431.
w x5 Yamamoto, S., Askew, G.R., Heiny, J., Masaki, H. and
 .Yatani, A. 1996 Am. J. Physiol. 270, C457–C464.
w x  .6 Kockskamper, J., Gisselmann, G. and Glitsch, H.G. 1996¨
Pflugers Arch. 431, R106.¨
w x  .7 Van Huysse, J.W., Jewell, E.A. and Lingrel, J.B. 1993
Biochemistry 32, 819–826.
w x  .8 Gorman, C.M., Gies, D.R. and McRay, G. 1990 DNA
Prot. Eng. Tech. 2, 3–10.
w x  .9 Bechem, M., Pott, L. and Rennebaum, H. 1983 Eur. J.
Cell Biol. 31, 366–369.
w x10 Banach, K., Huser, J., Lipp, P., Wellner, M.-C. and Pott, L.¨
 .1993 J. Physiol. 461, 263–281.
w x  .  .11 Fabiato, A. and Fabiato, F. 1979 J. Physiol. Paris 75,
463–505.
w x  .12 De Weer, P., Gadsby, D.C. and Rakowski, R.F. 1988
Annu. Rev. Physiol. 50, 225–241.
w x  .13 Bielen, F.V., Glitsch, H.G. and Verdonck, F. 1992
Naunyn-Schmiedeberg’s Arch. Pharmacol. 345, 100–107.
w x  .14 Berlin, J.R., Fielding, A.J. and Ishizuka, N. 1992 Ann.
N.Y. Acad. Sci. 671, 440–442.
w x  .15 Lucchesi, P.A. and Sweadner, K.J. 1991 J. Biol. Chem.
266, 9327–9331.
w x  .16 Sweadner, K.J. 1989 Biochim. Biophys. Acta 988, 185–
220.
w x  .17 Hermans, A.N., Glitsch, H.G. and Verdonck, F. 1995 J.
Physiol. 484, 617–628.
w x18 Cohen, I.S., Datyner, N.B., Gintant, G.A., Mulrine, N.K.
 .and Pennefather, P. 1987 J. Physiol. 383, 251–267.
w x  .19 Oike, M., Droogmans, G., Casteels, R. and Nilius, B. 1993
Pflugers Arch. 424, 301–307.¨
w x  .20 Kinard, T.A., Liu, X.-Y., Liu, S. and Stimers, J.R. 1994
Am. J. Physiol. 266, C37–C41.
w x  .21 Nakao, M. and Gadsby, D.C. 1989 J. Gen. Physiol. 94,
539–565.
w x22 Sakai, R., Hagiwara, N., Matsuda, N., Kasanuki, H. and
 .Hosoda, S. 1996 J. Physiol. 490, 51–62.
w x  .23 De Weer, P. 1992 in The Kidney: Physiology and Patho-
 .physiology Seldin, D.W. and Giebisch, G., eds. , pp. 93–
112. Raven Press, New York.
w x  .24 Hilgemann, D.W. 1994 Science 263, 1429–1432.
w x  .25 Nakao, M. and Gadsby, D.C. 1986 Nature 323, 628–630.
w x  .26 Gadsby, D.C., Kimura, J. and Noma, A. 1985 Nature 315,
63–65.
w x  .27 Glitsch, H.G., Krahn, T. and Pusch, H. 1989 Pflugers¨
Arch. 414, 52–58.
w x  .28 Stimers, J.R., Liu, S. and Kinard, T.A. 1993 J. Membr.
Biol. 135, 39–47.
w x  .29 Arguello, J.M. and Lingrel, J.B. 1995 J. Biol. Chem. 270,¨
22764–22771.
w x  .30 Jewell, E.A. and Lingrel, J.B. 1991 J. Biol. Chem. 266,
16925–16930.
w x  .31 Jewell-Motz, E.A. and Lingrel, J.R. 1993 Biochemistry 32,
13523–13530.
w x  .32 Schwarz, W. and Gu, Q. 1988 Biochim. Biophys. Acta
945, 167–174.
w x  .33 Vasilets, L.A. and Schwarz, W. 1993 Biochim. Biophys.
Acta 1154, 201–222.
w x34 Jaunin, P., Jaisser, F., Beggah, A.T., Takeyasu, K., Mangeat,
 .P., Rossier, B.C., Horisberger, J.-D. and Geering, K. 1993
J. Cell Biol. 123, 1751–1759.
w x  .35 Shanbaky, N.M. and Pressley, T.A. 1995 Biochem. Cell
Biol. 73, 261–268.
w x36 Putnam, D.S., Jewell, E.A., Lescale-Matys, L., Magyar,
 .C.E. and McDonough, A.A. 1994 in The Sodium Pump:
Structure Mechanism, Hormonal Control, and its Role in
 .Disease Bamberg, E. and Schoner, W., eds. , pp. 234–237.
Steinkopff, Darmstadt.
w x37 Kaji, D.M., Bates, J., Goyzueta, J.D., Prasadan, K., Yu, H.
 .and Kumar, S. 1996 J. Membr. Biol. 149, 49–55.
